Sedation for pharyngeal examination with transoral endoscopy: a comparative study of no sedation, midazolam and pethidine hydrochloride
Not Applicable
- Conditions
- pharyngeal cancer
- Registration Number
- JPRN-UMIN000016722
- Lead Sponsor
- Osaka Medical Center for Cancer and Cardiovascular Diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with pharyngeal cancer or patients who have history of pharyngeal cancer Patients with hematological abnormality Patients with severe organ failure Patients who have been judged as in appropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The score of suitable quality images at the 5 points as follows: uvula, posterior wall of oropharynx, epiglottic vallecula, right pyriform sinus and left pyriform sinus
- Secondary Outcome Measures
Name Time Method Pharyngeal observation time, Visual analogue scale score for discomfort after the pharyngeal examination
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie midazolam and pethidine hydrochloride sedation efficacy in transoral endoscopy for pharyngeal cancer (JPRN-UMIN000016722)?
How does midazolam vs pethidine hydrochloride sedation compare to standard-of-care agents in transoral endoscopy for pharyngeal cancer (JPRN-UMIN000016722)?
What biomarkers correlate with sedation response to midazolam or pethidine hydrochloride in pharyngeal cancer transoral endoscopy (JPRN-UMIN000016722)?
What adverse events and management strategies are reported for midazolam and pethidine hydrochloride in pharyngeal cancer endoscopy (JPRN-UMIN000016722)?
Are there alternative sedation regimens or combination therapies to midazolam and pethidine hydrochloride for transoral endoscopy in pharyngeal cancer (JPRN-UMIN000016722)?